Proteasome inhibition modeling nigral neuron degeneration in Parkinson’s disease. Wenjie Xie, Xuping Li, Chao Li, Wen Zhu, Joseph Jankovic, Weidong Le, Article first published online: 23 JUL 2010, DOI: 10.1111/j.1471-4159.2010.06914.x Journal of Neurochemistry Volume 115, Issue 1, pages 188–199, October 2010.
Disruption of neuropsin mRNA expression via RNA interference facilitates the photoinduced increase in thyrotropin-stimulating subunit β in birds. Tyler J. Stevenson and Gregory F. Ball. European Journal of Neuroscience, 8 JUL 2012, DOI: 10.1111/j.1460-9568.2012.08209.x
Linkage and association studies in African- and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence. M D Li, D Sun, X-Y Lou, J Beuten, T J Payne and J Z Ma. Molecular Psychiatry (2007) 12, 462–473. doi:10.1038/sj.mp.4001933; published online 19 December 2006
Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease. Chao Li, Yuan Guo, Wenjie Xie, Xingang Li, Joseph Janokovic and Weidong Le. Neurochemical Research Volume 35, Number 10 (2010), 1546-1556, DOI: 10.1007/s11064-010-0214-3.
Proteins differentially expressed in response to nicotine in five rat brain regions: Identification using a 2-DE/MS-based proteomics approach. Yoon Y. Hwang, Ming D. Li, Dr. Proteomics 6: 3138-3153, 2006.
Strain- and region-specific gene expression profiles in mouse brain in response to chronic nicotine treatment. J. Wang, R. Gutala, Y. Y. Hwang, J.-M. Kim, O. Konu, J. Z. Ma, M. D. Li. Genes, Brain and Behavior (OnlineEarly Articles).
Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. Justin K. Kanea, Özlen Konub, Jennie Z. Maa and Ming D. L. Molecular Brain Research Volume 132, Issue 2, 20 December 2004, Pages 181-191